Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for MLAB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 0.00
March 31, 2026 0.00
December 31, 2025 0.00
September 30, 2025 0.00
June 30, 2025 0.00
March 31, 2025 -2.644M
December 31, 2024 0.00
September 30, 2024 0.00
June 30, 2024 0.00
March 31, 2024 0.00
December 31, 2023 -0.002M
September 30, 2023 -0.304M
June 30, 2023 -0.052M
March 31, 2023 -2.474M
December 31, 2022 -0.881M
September 30, 2022 -2.206M
June 30, 2022 -1.436M
March 31, 2022 -1.80M
December 31, 2021 -2.271M
September 30, 2021 -1.992M
June 30, 2021 -1.089M
March 31, 2021 -0.734M
December 31, 2020 -0.991M
September 30, 2020 -1.047M
June 30, 2020 -147.59M
Date Value
March 31, 2020 -1.097M
December 31, 2019 -0.341M
September 30, 2019 -85.79M
June 30, 2019 -2.709M
March 31, 2019 -1.507M
December 31, 2018 -0.412M
September 30, 2018 -0.133M
June 30, 2018 -3.043M
March 31, 2018 -0.573M
December 31, 2017 -0.282M
September 30, 2017 -1.101M
June 30, 2017 -0.963M
March 31, 2017 -0.698M
December 31, 2016 -1.048M
September 30, 2016 -0.607M
June 30, 2016 -1.16M
March 31, 2016 -0.123M
December 31, 2015 -0.954M
September 30, 2015 -0.286M
June 30, 2015 -0.56M
March 31, 2015 -0.367M
December 31, 2014 -0.272M
September 30, 2014 -0.43M
June 30, 2014 -0.435M
March 31, 2014 -0.771M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Agilent Technologies, Inc. 44.00M
Bio-Rad Laboratories, Inc. 27.30M
Bruker Corp. 0.00
Danaher Corp. 885.00M
Harvard Bioscience, Inc. 0.00